Company Filing History:
Years Active: 2007-2010
Title: Gabor Sulyok: Innovator in Integrin-Inhibitor Compounds
Introduction
Gabor Sulyok is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptide and peptide mimetic conjugates with integrin-inhibitor properties. His work has the potential to impact the treatment of various medical conditions.
Latest Patents
Gabor Sulyok holds two notable patents. The first patent involves peptide and peptide mimetic conjugates that serve as integrin inhibitors. These compounds are designed to treat illnesses such as osteoporosis, thrombosis, cardiac infarction, and arteriosclerosis. The second patent also focuses on peptide and peptide mimetic derivatives with integrin-inhibitor properties, which can be used to enhance the integration process of implants in tissue.
Career Highlights
Sulyok is currently associated with Biomet Deutschland GmbH, where he continues to innovate in the field of biocompatible materials. His research is crucial for advancing medical treatments and improving patient outcomes.
Collaborations
He collaborates with notable colleagues, including Joerg Meyer and Berthold Nies, who contribute to his research endeavors.
Conclusion
Gabor Sulyok's work in developing integrin-inhibitor compounds showcases his dedication to advancing medical science. His patents reflect a commitment to improving healthcare solutions and addressing critical health challenges.